EP 0831799 B1 20030502 - COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS
Title (en)
COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS
Title (de)
VERBINDUNGEN, DIE AN EINER NEUEN STELLE AUF REZEPTOR-STIMULIERTEN KALZIUMKANÄLEN WIRKSAM SIND, VERWENDBAR ZUR BEHANDLUNG VON NEUROLOGISCHEN KRANKHEITEN
Title (fr)
COMPOSES ACTIFS AU NIVEAU D'UN NOUVEAU SITE DE CANAUX CALCIQUES ACTIVES PAR RECEPTEUR, UTILES DANS LE TRAITEMENT DE TROUBLES NEUROLOGIQUES
Publication
Application
Priority
- US 9610201 W 19960607
- US 48503895 A 19950607
Abstract (en)
[origin: WO9640097A1] Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, spinal cord ischemia, ischemia- or hypoxia-induced nerve cell damage, epilepsy, anxiety, neuropsychiatric or cognitive deficits due to ischemia or hypoxia such as those that frequency occur as a consequence of cardiac surgery under cardiopulmonary bypass, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amytrophic lateral sclerosis (ALS).
IPC 1-7
A61K 31/135; A61K 31/155; A61K 31/165; A61K 31/40; A61K 31/38; A61K 31/44; A61K 31/445
IPC 8 full level
C07D 295/02 (2006.01); A61K 31/135 (2006.01); A61K 31/136 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 31/295 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61K 31/395 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/44 (2006.01); A61K 31/4409 (2006.01); A61K 31/445 (2006.01); A61K 31/4462 (2006.01); A61K 31/4465 (2006.01); A61K 31/451 (2006.01); A61K 31/495 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01); C07C 211/26 (2006.01); C07C 211/27 (2006.01); C07C 211/28 (2006.01); C07C 211/29 (2006.01); C07C 211/40 (2006.01); C07C 211/54 (2006.01); C07C 215/28 (2006.01); C07C 215/54 (2006.01); C07C 217/10 (2006.01); C07C 217/18 (2006.01); C07C 217/26 (2006.01); C07C 217/48 (2006.01); C07C 217/60 (2006.01); C07C 217/62 (2006.01); C07C 217/72 (2006.01); C07C 233/13 (2006.01); C07C 233/22 (2006.01); C07C 235/34 (2006.01); C07C 237/22 (2006.01); C07C 279/14 (2006.01); C07D 207/08 (2006.01); C07D 207/12 (2006.01); C07D 207/20 (2006.01); C07D 209/18 (2006.01); C07D 209/42 (2006.01); C07D 211/10 (2006.01); C07D 211/18 (2006.01); C07D 213/30 (2006.01); C07D 213/38 (2006.01); C07D 227/00 (2006.01); C07D 333/20 (2006.01)
CPC (source: EP KR US)
A61K 31/135 (2013.01 - EP KR US); A61K 31/136 (2013.01 - EP US); A61K 31/137 (2013.01 - EP US); A61K 31/138 (2013.01 - EP US); A61K 31/155 (2013.01 - EP KR US); A61K 31/165 (2013.01 - EP US); A61K 31/295 (2013.01 - EP US); A61K 31/381 (2013.01 - EP US); A61K 31/40 (2013.01 - EP US); A61K 31/4409 (2013.01 - EP US); A61K 31/4462 (2013.01 - EP US); A61K 31/4465 (2013.01 - EP US); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 211/27 (2013.01 - EP US); C07C 211/28 (2013.01 - EP US); C07C 211/29 (2013.01 - EP US); C07C 211/40 (2013.01 - EP US); C07C 211/54 (2013.01 - EP US); C07C 215/28 (2013.01 - EP US); C07C 215/54 (2013.01 - EP US); C07C 217/10 (2013.01 - EP US); C07C 217/48 (2013.01 - EP US); C07C 217/60 (2013.01 - EP US); C07C 217/62 (2013.01 - EP US); C07C 233/13 (2013.01 - EP US); C07C 233/22 (2013.01 - EP US); C07C 235/34 (2013.01 - EP US); C07C 237/22 (2013.01 - EP US); C07C 279/14 (2013.01 - EP US); C07D 207/08 (2013.01 - EP US); C07D 207/12 (2013.01 - EP US); C07D 207/20 (2013.01 - EP US); C07D 209/42 (2013.01 - EP US); C07D 211/18 (2013.01 - EP US); C07D 213/30 (2013.01 - EP US); C07D 213/38 (2013.01 - EP US); C07D 333/20 (2013.01 - EP US); C07B 2200/07 (2013.01 - EP US); C07C 2601/08 (2017.04 - EP US); C07C 2601/14 (2017.04 - EP US)
Citation (examination)
US 5281624 A 19940125 - GEHLERT DONALD R [US], et al
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9640097 A1 19961219; AT E238782 T1 20030515; AU 6112596 A 19961230; AU 716122 B2 20000217; BR 9609019 A 19990706; CA 2223978 A1 19961219; CN 1153568 C 20040616; CN 1192679 A 19980909; DE 69627852 D1 20030605; DE 69627852 T2 20040226; DK 0831799 T3 20030811; EP 0831799 A1 19980401; EP 0831799 B1 20030502; ES 2197945 T3 20040116; HK 1008980 A1 19990521; JP H11506469 A 19990608; KR 100430022 B1 20040716; KR 19990022588 A 19990325; NZ 310344 A 20010330; PL 185492 B1 20030530; PL 323871 A1 19980427; PT 831799 E 20030930; RU 2246300 C2 20050220; US 6051610 A 20000418; US 6071970 A 20000606
DOCDB simple family (application)
US 9610201 W 19960607; AT 96918477 T 19960607; AU 6112596 A 19960607; BR 9609019 A 19960607; CA 2223978 A 19960607; CN 96196042 A 19960607; DE 69627852 T 19960607; DK 96918477 T 19960607; EP 96918477 A 19960607; ES 96918477 T 19960607; HK 98109748 A 19980806; JP 50223897 A 19960607; KR 19970709069 A 19971206; NZ 31034496 A 19960607; PL 32387196 A 19960607; PT 96918477 T 19960607; RU 98100454 A 19960607; US 25243399 A 19990218; US 48503895 A 19950607